Identification of FDA-Approved Drugs with Activity against Stationary Phase <em>Bartonella henselae</em>
<i>Bartonella henselae</i> can cause various infections in humans, ranging from benign and self-limiting diseases to severe and life-threatening diseases as well as persistent infections that are difficult to treat. To develop more effective treatments for persistent Bartonella infections, in this s...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2019-04-01
|
| Edice: | Antibiotics |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2079-6382/8/2/50 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
